跳至主要内容
临床试验/NCT03267199
NCT03267199撤回不适用

The Relationship Between Mean Platelet Volume , Platelet Distribution Width , Platelet Function and ST Segment Resolution in STEMI Patients Treated With Either Thrombolytic Therapy or Primary Percutaneous Coronary Intervention

Assiut University0 个研究点开始时间: 2020年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
主要终点
Correlation between admission MPV ,PDW ,platelet function test and change in ST-segment elevation in STEMI patients assessed by CBC ,platelet function test & ECG

研究概览

简要总结

  • The relationship between admission MPV, PDW, platelet function test and ST-segment resolution in STEMI patients treated with either thrombolytic therapy or primary percutaneous coronary intervention
  • The relationship between admission MPV, PDW, platelet function test and high thrombus burden & post-PCI Thrombolysis In Myocardial Infarction (TIMI) flow of infarct related artery in STEMI patients treated with primary percutaneous coronary intervention

详细描述

Reperfusion therapy as the main treatment strategy in patients with ST-segment elevation myocardial infarction (STEMI) consists of either thrombolysis or primary percutaneous coronary intervention (pPCI). Primary percutaneous coronary intervention is the preferred therapy for STEMI; however, cardiac catheterization laboratories may not be widely available.

Early recanalization of the infarct related artery (IRA) by either thrombolytics or percutaneous coronary intervention (PCI) is the main goal in the treatment of acute myocardial infarction. But the eventual aim is to provide reperfusion at the tissue level as well as in the infarct related artery .

Resolution of ST elevation has been shown as an agreeable marker that reflects both epicardial and myocardial reperfusion . In addition, early and complete resolution of ST -segment in the setting of acute myocardial infarction is associated with smaller infarct size, greater ejection fraction and reduced morbidity and mortality .

Platelets play a critical role in the pathogenesis and prognosis of ACS . They secrete a number of substances that are key mediators of coagulation, thrombosis and atherosclerosis. High-volume platelets have a higher thrombotic potential than small platelets and have concentrated granule contents that are of interest in the development of ACS pathogenesis . Mean platelet volume (MPV) is the most commonly used measure of platelet size and correlates with platelet activity. Platelet distribution width (PDW) is an index reflecting heterogeneous platelet size, whereas the platelet-large cell ratio (P-LCR) is the proportion of large platelets in blood circulation. Generally, higher MPV, PDW and P-LCR are correlated with increased platelet size, although they tend to be overlooked in clinical applications. In fact, these indices, particularly MPV and PDW, correlate with platelet functions.

Percutaneous coronary intervention (PCI) is an effective treatment for acute coronary syndrome (ACS), including ST-elevation myocardial infarction (STEMI) and unstable angina. Despite the efficacy of the technique, preprocedural high-thrombus burden (HTB) is a predictor of procedural complications following primary PCI for STEMI. HTB can lead to poor outcomes, including distal embolization, no-reflow, increased myocardial necrosis and decreased left ventricular function.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • patients with STEMI presented who will be treated with either thrombolytic therapy or primary PCI in assiut university cath lab will be included in the study

排除标准

  • Patient with complete LBBB on admission ECG
  • Active infection
  • Documented systemic inflammatory disease
  • Malignancy
  • End-stage liver
  • Renal failure
  • Patient receiving oral anticoagulation medicine
  • Bleeding diathesis

研究组 & 干预措施

patients with high MPV,PDW,PFT

patients with high MPV,PDW,platelet function test

干预措施: Thrombolytic (Drug)

patients with high MPV,PDW,PFT

patients with high MPV,PDW,platelet function test

干预措施: Primary PCI (Procedure)

patients with high MPV,PDW,PFT

patients with high MPV,PDW,platelet function test

干预措施: Complete blood count (Diagnostic Test)

patients with high MPV,PDW,PFT

patients with high MPV,PDW,platelet function test

干预措施: Platelet function test (Diagnostic Test)

patients with high MPV,PDW,PFT

patients with high MPV,PDW,platelet function test

干预措施: ECG (Diagnostic Test)

patients with normal or low MPV,PDW, PFT

patients with normal or low MPV,PDW,platelet function test

干预措施: Thrombolytic (Drug)

patients with normal or low MPV,PDW, PFT

patients with normal or low MPV,PDW,platelet function test

干预措施: Primary PCI (Procedure)

patients with normal or low MPV,PDW, PFT

patients with normal or low MPV,PDW,platelet function test

干预措施: Complete blood count (Diagnostic Test)

patients with normal or low MPV,PDW, PFT

patients with normal or low MPV,PDW,platelet function test

干预措施: Platelet function test (Diagnostic Test)

patients with normal or low MPV,PDW, PFT

patients with normal or low MPV,PDW,platelet function test

干预措施: ECG (Diagnostic Test)

结局指标

主要结局

Correlation between admission MPV ,PDW ,platelet function test and change in ST-segment elevation in STEMI patients assessed by CBC ,platelet function test & ECG

时间窗: Baseline and 90 min after either the beginning treatment with thrombolytic therapy or primary PCI

Correlation between admission MPV ,PDW ,platelet function test and change in ST-segment elevation in STEMI patients treated with either thrombolytic therapy or primary percutaneous coronary intervention assessed by CBC,platelet function test \& ECG

次要结局

  • Correlation between MPV,PDW,platelet function test and TIMI flow of infarct related artery in STEMI patients treated with primary PCI(Baseline)
  • Correlation between MPV,PDW,platelet function test and high thrombus burden of infarct related artery in STEMI patients treated with primary PCI(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nardeen Beshay

resident physician

Assiut University

相似试验